SynthesisFrontiers in neuroscience2025
Frontiers of optic nerve regeneration research: an analysis of the top 100 most influential articles in the field from 2005 to 2025.
Synthesis in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: In this study, we evaluated the key features of the 100 most-cited publications on optic nerve regeneration from 2005 to 2025 employing bibliometric and visual analysis. Methods: The data for this study were obtained from a comprehensive search across multiple databases, including the Web of Science, Scopus, and Dimensions. We identified the top 100 most-cited articles published in each database from 2005 to 2025, merged and deduplicated the results, and selected the 100 most-cited papers on optic nerve regeneration. After extracting key details such as titles, authors, keywords, publication information, and institutional affiliations, a bibliometric analysis was conducted. Results: The top 100 most cited papers on optic nerve regeneration published between 2005 and 2025, accumulating 34,636 total citations with a median of 346 citations per paper. Prof. Zhigang He emerged as the most prolific author with 19 publications. The United States contributed 59 papers, while Harvard University led institutions with 30 publications. Key research themes included optic nerve regeneration, CNTF, gene therapy, and retinal ganglion cells. Conclusion: Our analysis of top-cited optic nerve regeneration research reveals sustained United States leadership in output and innovation. Early work focused on neuronal signaling pathways (PTEN/mTOR, KLF family), while current studies explore novel targets and biomaterials. Global collaboration among the United States, China, and European nations has accelerated progress. Key challenges remain in achieving functional long-distance regeneration. Future direction should prioritize the development of multi-target therapeutic methods, precise drug delivery, and the control of inflammation to improve nerve regeneration efficiency.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.